Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2002 1
2003 5
2004 2
2005 3
2006 3
2007 5
2008 4
2009 4
2010 4
2011 7
2012 5
2013 9
2014 13
2015 6
2016 3
2017 4
2018 1
2019 8
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

86 results
Results by year
Filters applied: . Clear all
Page 1
Highly conserved influenza T cell epitopes induce broadly protective immunity.
Eickhoff CS, Terry FE, Peng L, Meza KA, Sakala IG, Van Aartsen D, Moise L, Martin WD, Schriewer J, Buller RM, De Groot AS, Hoft DF. Eickhoff CS, et al. Among authors: Martin WD, De Groot AS. Vaccine. 2019 Aug 23;37(36):5371-5381. doi: 10.1016/j.vaccine.2019.07.033. Epub 2019 Jul 19. Vaccine. 2019. PMID: 31331771
HLA- and genotype-based risk assessment model to identify infantile onset pompe disease patients at high-risk of developing significant anti-drug antibodies (ADA).
De Groot AS, Kazi ZB, Martin RF, Terry FE, Desai AK, Martin WD, Kishnani PS. De Groot AS, et al. Among authors: Martin RF, Martin WD. Clin Immunol. 2019 Mar;200:66-70. doi: 10.1016/j.clim.2019.01.009. Epub 2019 Jan 31. Clin Immunol. 2019. PMID: 30711607 Free PMC article.
Publisher Correction: A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines.
Wada Y, Nithichanon A, Nobusawa E, Moise L, Martin WD, Yamamoto N, Terahara K, Hagiwara H, Odagiri T, Tashiro M, Lertmemongkolchai G, Takeyama H, De Groot AS, Ato M, Takahashi Y. Wada Y, et al. Among authors: Martin WD, De Groot AS. Sci Rep. 2019 Oct 8;9(1):14730. doi: 10.1038/s41598-019-50828-3. Sci Rep. 2019. PMID: 31594990 Free PMC article.
Promiscuous Coxiella burnetii CD4 Epitope Clusters Associated With Human Recall Responses Are Candidates for a Novel T-Cell Targeted Multi-Epitope Q Fever Vaccine.
Scholzen A, Richard G, Moise L, Baeten LA, Reeves PM, Martin WD, Brauns TA, Boyle CM, Raju Paul S, Bucala R, Bowen RA, Garritsen A, De Groot AS, Sluder AE, Poznansky MC. Scholzen A, et al. Among authors: Martin WD, De Groot AS. Front Immunol. 2019 Feb 15;10:207. doi: 10.3389/fimmu.2019.00207. eCollection 2019. Front Immunol. 2019. PMID: 30828331 Free PMC article.
Agility in adversity: Vaccines on Demand.
De Groot AS, Moise L, Olive D, Einck L, Martin W. De Groot AS, et al. Among authors: Martin W. Expert Rev Vaccines. 2016 Sep;15(9):1087-91. doi: 10.1080/14760584.2016.1205951. Epub 2016 Jul 18. Expert Rev Vaccines. 2016. PMID: 27389971 Review.
T cell epitope engineering: an avian H7N9 influenza vaccine strategy for pandemic preparedness and response.
Moise L, M Biron B, Boyle CM, Kurt Yilmaz N, Jang H, Schiffer C, M Ross T, Martin WD, De Groot AS. Moise L, et al. Among authors: Martin WD, De Groot AS. Hum Vaccin Immunother. 2018;14(9):2203-2207. doi: 10.1080/21645515.2018.1495303. Epub 2018 Sep 5. Hum Vaccin Immunother. 2018. PMID: 30015562 Free PMC article. Review.
Tregitope: Immunomodulation powerhouse.
Cousens L, Najafian N, Martin WD, De Groot AS. Cousens L, et al. Among authors: Martin WD, De Groot AS. Hum Immunol. 2014 Dec;75(12):1139-46. doi: 10.1016/j.humimm.2014.10.012. Epub 2014 Oct 22. Hum Immunol. 2014. PMID: 25454619 Free article.
Tregitope peptides: the active pharmaceutical ingredient of IVIG?
De Groot AS, Cousens L, Mingozzi F, Martin W. De Groot AS, et al. Among authors: Martin W. Clin Dev Immunol. 2013;2013:493138. doi: 10.1155/2013/493138. Epub 2013 Dec 25. Clin Dev Immunol. 2013. PMID: 24454476 Free PMC article. Review.
86 results
Jump to page
Feedback